Shares of T2 Biosystems extended their losing streak to two days Wednesday.
You are here: Home / Top Stories / : T2 Biosystems’ stock extends losing streak despite FDA approval for anthrax and plague diagnostic test
Market News and Views
Shares of T2 Biosystems extended their losing streak to two days Wednesday.